A SITC corporate membership provides organizations in the field of cancer immunotherapy and cancer research a forum to address common issues impacting the field with the goal of improving cancer patient outcomes.

Benefits of a SITC corporate membership program include:

  • Industry Roundtable: SITC engages industry leaders to address key issues and hurdles in the field. SITC corporate member representatives participate in the meetings organized around key issues that affect their interests
  • Private meeting with SITC leadership: SITC corporate members receive exclusive access to SITC leadership through a private meeting each year at a location and time amenable to both parties
  • Priority opportunity to register for or sponsor annual SITC Think Tanks: which will include exclusive invitations to send company representatives to think tanks. Additional costs will apply. Examples of past Think Tanks include Leveraging Biomarkers Workshop, Surrogate Endpoints Summit, and Release Criteria Workshop.
  • Recurring check-ins with SITC Staff: Corporate members have the opportunity to meet regularly with SITC's Executive Director and Director of Development to discuss strategic partnership opportunities, provide feedback on collaborative initiatives, stay informed about SITC programs and priorities, and explore ways to align mutual goals for advancing cancer immunotherapy.

Dues for SITC corporate memberships are determined by the size of the organization. The dues structure is as follows:

  • < 250 employees = $10,000 annual dues
  • 251-1,000 employees = $25,000 annual dues
  • 1,001-5,000 employees = $40,000 annual dues
  • 5,001- 10,000 employees = $55,000 annual dues
  • 10,001-20,000 employees = $80,000 annual dues
  • > 20,000 employees = $100,000 annual dues

SITC is proud to be a broker of new relationships among the individuals leading the next generation of cancer immunotherapy research.